A breath of salty air for patients with cystic fibrosis
In a seemingly random but nevertheless important discovery, scientists watching surfers with cystic fibrosis in Australia several years ago found that inhaling sea water mist reduced lung problems associated with the inherited disease.
So Cambridge Consultants in the U.K. paired with pharma firm Parion to develop and design a type of aerosol delivery systemt, called trans-nasal pulmonary aerosol delivery (tPAD), that brings the benefits of salt water treatment to the comfort of patients' homes, working overnight while they sleep.… Read more
